Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine (Q84592118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Mark S Riddle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Robert W Kaminski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Carlos Williams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chad Porter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shahida Baqar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Alexis Kordis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Theron Gilliland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Joyce Lapa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Melissa Coughlin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chris Soltis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Erica Jones

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jackie Saunders

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Paul B Keiser

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ryan T Ranallo

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Robert Gormley

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Michael Nelson

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Ross Turbyfill

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

David Tribble

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Edwin V Oaks

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

23 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

7009-7019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of travelers' diarrhea and relative importance of various pathogens.

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Gastroenteritis in US Marines during Operation Iraqi Freedom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Inactivated and subunit vaccines to prevent shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Shigellosis: the current status of vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Mucosal adjuvant properties of the Shigella invasin complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

Diarrheal disease among military personnel during Operation Restore Hope, Somalia, 1992-1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

7 January 2021

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

7 January 2021

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

7 January 2021

Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.033

7 January 2021

10.1016/J.VACCINE.2011.07.033

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21787825%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference